Skip to main content
European Commission logo
français français
CORDIS - Résultats de la recherche de l’UE
CORDIS
CORDIS Web 30th anniversary CORDIS Web 30th anniversary
Contenu archivé le 2024-06-16

Safety and efficacy for new techniques and imaging using new equipment to support European legislation.

Objectif

Health services in the EU are a growing fraction of national wealth, typically 10% of GDP. Within this radiological imaging is gaining increasing prominence and now accounts for up to 10% of hospital revenue and 15% of capital equipment budgets, thereby identifying it as an investment of major social importance.This increase has been driven by new developments in equipment, digital imaging, medical devices, and IT industries; paralleled by novel clinical practices and modalities. Striking examples include the introduction of digital technologies to replace film, and the range of sophisticated angiographic techniques now used widely.This proposal deals with radiation protection, safety, and related issues that arise from these developments. It covers over 90% of patient examinations, 60% of the collective dose from medical sources, and approximately 50% of the collective dose from man-made sources.In practice this proposal deals with almost all radiological digital imaging outside of CT Scanning.This proposal is essential, as at present development is entirely driven by the combined and essentially global forces of the industry on one side, and the clinical users on the other.There has been no parallel investment in research on the protection, safety, efficacy, optimisation, justification, and ethical issues (despite a certain amount of regulatory development).This deficit is now evident, as day-to-day practice has outpaced the available statutory safety and standards framework. Undertaking the proposed programme, which spans: Functional and Objective Equipment Performance and International Standards Dosimetry,Constancy Testing and QA Justification,Ethics, and Efficacy Guidelines, Good Practice, and Training Materials will underwrite the safety, efficacy and ethical aspects of clinical practice, while protecting and adding value to the products and of the associated knowledge based equipment, devices, IT, and services industries.

Programme(s)

Thème(s)

Data not available

Appel à propositions

EURATOMCALL2004-FIXEDDEADLINE
Voir d’autres projets de cet appel

Régime de financement

CA - Coordination action

Coordinateur

NORTHUMBERLAND, TYNE & WEAR STRATEGIC HEALTH AUTHORITY
Contribution de l’UE
Aucune donnée
Adresse
Riverside House, The Waterfront, Goldcrest Way, Newburn Riverside
NEWCASTLE UPON TYNE
Royaume-Uni

Voir sur la carte
Liens
Coût total
Aucune donnée

Participants (22)

Partager cette page

Télécharger

Dernière mise à jour: 26 Mars 2013

Mon livret

Permalink: https://cordis.europa.eu/project/id/12909/fr

European Union, 2024